Compared side by side
NAD+ vs MOTS-c: how they differ
The short answer
Both are run for cellular energy, at different levels: NAD+ is the coenzyme every cell needs to turn food into energy, and MOTS-c is a peptide encoded by mitochondrial DNA that, in mice, activates AMPK, the pathway exercise triggers. Injected NAD+ has little controlled data, and no human trial has tested MOTS-c yet. NAD+ is taken daily or every other day, MOTS-c 2–3 times a week.
Side by side
| Compared | NAD+ | MOTS-c |
|---|---|---|
| Category | Longevity | Longevity |
| Also known as | Nicotinamide adenine dinucleotide, NAD, NAD plus | Mitochondrial Open Reading Frame of the 12S rRNA-c |
| What it is | NAD+ is a coenzyme every cell needs to turn food into usable energy, and the molecule your sirtuin "longevity" enzymes and DNA-repair machinery run on. | A peptide encoded by your mitochondrial DNA, the energy-producing organelles inside every cell. |
| How it works | Central coenzyme in cellular energy metabolism (redox reactions in glycolysis, the TCA cycle, and oxidative phosphorylation). Also the required substrate for sirtuins (SIRT1-7) and PARP DNA-repair enzymes. NAD+ falls with age in some tissues (the human data are mixed); supplementation aims to restore the pool that powers mitochondrial function, DNA repair, and metabolic signaling. | Mitochondria-derived peptide that regulates metabolic homeostasis. In mouse and cell studies it activates the AMPK pathway, improves insulin sensitivity and exercise capacity, and slows some signs of aging. |
| Commonly reported | A lift in energy and mental clarity within days, and flushing or nausea when it goes in too fast. Most human evidence is for the oral precursors (NMN and NR); injected NAD+ is popular but has little controlled data. | More energy and better workout endurance over the first weeks, sometimes after a week or two of feeling tired. No human trial has tested it yet. |
| Studied range | Research range: 50–100 mg, starting dose 50 mg. Studied in research — not a recommendation. | Research range: 5–10 mg. Studied in research — not a recommendation. |
| How often | Daily or EOD | 2–3× weekly |
| Half-life | Minutes (rapidly metabolized) | Hours (short) |
| Route | SubQ injection, IV infusion, Intranasal | SubQ injection, IM injection |
| Typical run | Often run in 2–6 week blocks, 2–3× per year, or low-dose continuous. Inject slowly — the hallmark NAD+ flush/nausea is dose-RATE dependent, not dose-amount dependent. No standardized injectable protocol exists; ranges are extrapolated from IV practice + community use. Often stacked with glutathione. | 4–8 week cycles common, 2–3× per year. Common splits: Mon/Thu (2× weekly) or Mon/Wed/Fri (3× weekly). Limited long-term human data — none on continuous dosing. |
| Evidence | Emerging: primarily preclinical / limited human data | Emerging: primarily preclinical / limited human data |
| Common side effects | Flushing, nausea if dosed too fast, injection site stinging, transient chest tightness (fast IV) | Injection site reaction, mild fatigue first week |
- Category
- NAD+Longevity
- MOTS-cLongevity
- Also known as
- NAD+Nicotinamide adenine dinucleotide, NAD, NAD plus
- MOTS-cMitochondrial Open Reading Frame of the 12S rRNA-c
- What it is
- NAD+NAD+ is a coenzyme every cell needs to turn food into usable energy, and the molecule your sirtuin "longevity" enzymes and DNA-repair machinery run on.
- MOTS-cA peptide encoded by your mitochondrial DNA, the energy-producing organelles inside every cell.
- How it works
- NAD+Central coenzyme in cellular energy metabolism (redox reactions in glycolysis, the TCA cycle, and oxidative phosphorylation). Also the required substrate for sirtuins (SIRT1-7) and PARP DNA-repair enzymes. NAD+ falls with age in some tissues (the human data are mixed); supplementation aims to restore the pool that powers mitochondrial function, DNA repair, and metabolic signaling.
- MOTS-cMitochondria-derived peptide that regulates metabolic homeostasis. In mouse and cell studies it activates the AMPK pathway, improves insulin sensitivity and exercise capacity, and slows some signs of aging.
- Commonly reported
- NAD+A lift in energy and mental clarity within days, and flushing or nausea when it goes in too fast. Most human evidence is for the oral precursors (NMN and NR); injected NAD+ is popular but has little controlled data.
- MOTS-cMore energy and better workout endurance over the first weeks, sometimes after a week or two of feeling tired. No human trial has tested it yet.
- Studied range
- NAD+Research range: 50–100 mg, starting dose 50 mg. Studied in research — not a recommendation.
- MOTS-cResearch range: 5–10 mg. Studied in research — not a recommendation.
- How often
- NAD+Daily or EOD
- MOTS-c2–3× weekly
- Half-life
- NAD+Minutes (rapidly metabolized)
- MOTS-cHours (short)
- Route
- NAD+SubQ injection, IV infusion, Intranasal
- MOTS-cSubQ injection, IM injection
- Typical run
- NAD+Often run in 2–6 week blocks, 2–3× per year, or low-dose continuous. Inject slowly — the hallmark NAD+ flush/nausea is dose-RATE dependent, not dose-amount dependent. No standardized injectable protocol exists; ranges are extrapolated from IV practice + community use. Often stacked with glutathione.
- MOTS-c4–8 week cycles common, 2–3× per year. Common splits: Mon/Thu (2× weekly) or Mon/Wed/Fri (3× weekly). Limited long-term human data — none on continuous dosing.
- Evidence
- NAD+Emerging: primarily preclinical / limited human data
- MOTS-cEmerging: primarily preclinical / limited human data
- Common side effects
- NAD+Flushing, nausea if dosed too fast, injection site stinging, transient chest tightness (fast IV)
- MOTS-cInjection site reaction, mild fatigue first week
Typical run: Community practice — opinions vary. Not a clinical recommendation.

Week by week
Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.
NAD+
- Day 1–14 Refilling the cellular battery
- Day 14–42 Where steady-state effects show up
- Day 42–84 A good point to take stock
MOTS-c
- Day 1–14 The first two weeks
- Day 14–28 Workouts often feel easier
- Day 28–56 Weeks 4 to 8: check your markers
- Day 56–84 Diminishing returns + cycle point
Together or one or the other
NAD+ and MOTS-c are a common stack: NAD+ lists MOTS-c among its common stacks.
Community · NAD+
Why NAD+ pairs with mitochondrial peptides
Different levers on the same system. NAD+ refills the coenzyme pool your mitochondria and sirtuins burn through; MOTS-c pushes the AMPK exercise-mimetic pathway. Complementary inputs to mitochondrial health rather than two versions of the same thing.
Questions people ask
How long do NAD+ and MOTS-c last?
The half-life of NAD+ is minutes (rapidly metabolized). The half-life of MOTS-c is hours (short).
How often are NAD+ and MOTS-c taken?
NAD+: daily or EOD. Routes: SubQ injection, IV infusion, intranasal. MOTS-c: 2–3× weekly. Routes: SubQ injection, IM injection.
How are NAD+ and MOTS-c dosed in research?
The research range for NAD+ is 50–100 mg, with a 50 mg starting dose. The research range for MOTS-c is 5–10 mg. Studied in research — not a recommendation.
What are the common side effects of NAD+ and MOTS-c?
For NAD+, the library lists: flushing, nausea if dosed too fast, injection site stinging, transient chest tightness (fast IV). For MOTS-c: injection site reaction, mild fatigue first week.
Are NAD+ and MOTS-c taken together?
NAD+ and MOTS-c are a common stack: NAD+ lists MOTS-c among its common stacks. Different levers on the same system. NAD+ refills the coenzyme pool your mitochondria and sirtuins burn through; MOTS-c pushes the AMPK exercise-mimetic pathway. Complementary inputs to mitochondrial health rather than two versions of the same thing.